The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT)

por Huntgeburth, Michael, Kießling, Johannes, Weimann, Gerrit, Kiepsel, Verena, Saleh, Soundos, Hunzelmann, Nicolas, Rosenkranz, Stephan
Publicado 2015